{"id":3992,"date":"2021-08-25T14:30:52","date_gmt":"2021-08-25T05:30:52","guid":{"rendered":"https:\/\/www.peptide.co.jp\/en\/?p=3992"},"modified":"2023-08-29T10:14:32","modified_gmt":"2023-08-29T01:14:32","slug":"4369","status":"publish","type":"post","link":"https:\/\/www.peptide.co.jp\/en\/new-product\/4369.html","title":{"rendered":"Effective and Safe Vaccine Adjuvant \/ New Lipid A"},"content":{"rendered":"

We have released new Lipid A from Alcaligenes faecalis<\/i>.
\nThis is highly homogeneous chemically synthesized product, and there is no contamination from natural source.
\nLipid A (Alcaligenes faecalis<\/i>) can be used as an effective and safe vaccine adjuvant.
\n\u3000
\n\u3000
\n\"Lipid<\/p>\n

Structure of Lipid A (Alcaligenes faecalis<\/i>)<\/p>\n

\u3000
\n\u30fbThis product is for research use only, not for use in humans.
\n\u30fbLicensed from National Institutes of Biomedical Innovation, Health and Nutrition and The Research Foundation for Microbial Diseases of Osaka University.
\n\u3000
\n\u3000<\/p>\n\n\n\n\n
Code<\/td>\nCompound<\/td>\nQuantity<\/td>\n<\/tr>\n
24018-s<\/a><\/td>\nLipid A (Alcaligenes faecalis<\/i>)<\/td>\n0.1 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u3000
\n\u3000
\n[Related Products]<\/p>\n\n\n\n\n\n\n
Code<\/td>\nCompound<\/td>\nQuantity<\/td>\n<\/tr>\n
24005-s<\/a><\/td>\nLipid A (E.coli<\/i>)<\/td>\n0.1 mg<\/td>\n<\/tr>\n
24006-s<\/a><\/td>\nLipid IVa<\/td>\n0.1 mg<\/td>\n<\/tr>\n
24008-s<\/a><\/td>\nLipid A (Salmonella<\/i>)<\/td>\n0.1 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u3000<\/p>\n

<\/div>\n
<\/div>\n

Feel free to contact us if you have any questions.
\n<\/a><\/Div>
\n\u3000<\/p>\n
\n
    \n
  1. WO2018155051A1.<\/li>\n
  2. A. Shimoyama, F.D. Lorenzo, H. Yamaura, K. Mizote, A. Palmigiano, M.D. Pither, I. Speciale, T. Uto, S. Masui, L. Sturiale, D. Garozzo, K. Hosomi, N. Shibata, K. Kabayama, Y. Fujimoto, A. Silipo, J. Kunisawa, H. Kiyono, A. Molinaro, and K. Fukase, Angew. Chem. Int. Ed<\/i>., 60<\/b>, 10023 (2021). DOI: 10.1002\/anie.202012374<\/a><\/li>\n
  3. Y. Wang, K. Hosomi, A. Shimoyama, K. Yoshii, H. Yamaura, T. Nagatake, T. Nishino, H. Kiyono, K. Fukase, and J. Kunisawa, Vaccines<\/i>, 8<\/b>, 395 (2020).DOI: 10.3390\/vaccines8030395<\/a><\/li>\n
  4. K. Yoshii, K. Hosomi, A. Shimoyama, Y. Wang, H. Yamaura, T. Nagatake, H. Suzuki, H. Lan, H. Kiyono, K. Fukase, and J. Kunisawa, <i.Microorganisms<\/i>, 8<\/b>, 1102 (2020). DOI: 10.3390\/microorganisms8081102<\/a><\/li>\n","protected":false},"excerpt":{"rendered":"

    We have released new Lipid A from Alcaligenes faecalis. This is highly homogeneous chemically synthesized prod […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/posts\/3992"}],"collection":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3992"}],"version-history":[{"count":5,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/posts\/3992\/revisions"}],"predecessor-version":[{"id":4926,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/posts\/3992\/revisions\/4926"}],"wp:attachment":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/categories?post=3992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/tags?post=3992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}